These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11996504)

  • 1. Cytochrome p450 and parkinsonism: protective role of CYP2E1.
    Vaglini F; Pardini C; Viaggi C; Corsini GU
    Funct Neurol; 2001; 16(4 Suppl):107-12. PubMed ID: 11996504
    [No Abstract]   [Full Text] [Related]  

  • 2. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Vaglini F; Pardini C; Viaggi C; Bartoli C; Dinucci D; Corsini GU
    J Neurochem; 2004 Oct; 91(2):285-98. PubMed ID: 15447662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CYP2E1 in the mouse model of MPTP toxicity.
    Pardini C; Vaglini F; Viaggi C; Caramelli A; Corsini GU
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S119-23. PubMed ID: 18583171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 isozymes involved in the metabolism of phenol, a benzene metabolite.
    Powley MW; Carlson GP
    Toxicol Lett; 2001 Dec; 125(1-3):117-23. PubMed ID: 11701230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2E1--biochemical and toxicological aspects and role in alcohol-induced liver injury.
    Cederbaum AI
    Mt Sinai J Med; 2006 Jul; 73(4):657-72. PubMed ID: 16878272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
    Abdulla D; Goralski KB; Renton KW
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1.
    Forkert PG; Baldwin RM; Millen B; Lash LH; Putt DA; Shultz MA; Collins KS
    Drug Metab Dispos; 2005 Oct; 33(10):1429-37. PubMed ID: 15987776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of MPTP in Parkinson's disease: connecting brain and gut?
    Goetze O; Woitalla D
    Exp Neurol; 2008 Apr; 210(2):281-5. PubMed ID: 18279853
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial targeting of intact CYP2B1 and CYP2E1 and N-terminal truncated CYP1A1 proteins in Saccharomyces cerevisiae--role of protein kinase A in the mitochondrial targeting of CYP2E1.
    Sepuri NB; Yadav S; Anandatheerthavarada HK; Avadhani NG
    FEBS J; 2007 Sep; 274(17):4615-30. PubMed ID: 17697118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The modeling of interactions of the CYP2E1 isoform of human cytochrome P450 with substrates].
    Potemkin VA; Grishina MA; Bartashevich EV; Zrakova TIu; Pogrebnoĭ AA
    Biofizika; 2005; 50(3):418-22. PubMed ID: 15977830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
    Huan JY; Streicher JM; Bleyle LA; Koop DR
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 reconstitution systems.
    Shimada T; Yamazaki H
    Methods Mol Biol; 1998; 107():85-93. PubMed ID: 14577215
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver.
    Bradford BU; Kono H; Isayama F; Kosyk O; Wheeler MD; Akiyama TE; Bleye L; Krausz KW; Gonzalez FJ; Koop DR; Rusyn I
    Hepatology; 2005 Feb; 41(2):336-44. PubMed ID: 15660387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minipig cytochrome P450 2E1: comparison with human enzyme.
    Baranová J; Anzenbacherová E; Anzenbacher P; Soucek P
    Drug Metab Dispos; 2005 Jun; 33(6):862-5. PubMed ID: 15778271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions.
    Wilkinson GR
    Clin Pharmacol Ther; 2004 Aug; 76(2):99-103. PubMed ID: 15289786
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytochrome P450 gene polymorphisms and risk of low birth weight.
    Chen D; Hu Y; Yang F; Li Z; Wu B; Fang Z; Li J; Wang L
    Genet Epidemiol; 2005 May; 28(4):368-75. PubMed ID: 15712341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1.
    Anzenbacherová E; Baranová J; Zuber R; Pechová A; Anzenbacher P; Soucek P; Martínková J
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):244-5. PubMed ID: 15733222
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
    Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.